Research Article
Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease
Table 3
Procedural characteristics.
| | | Overall population (n = 1198) | Nondiabetic (n = 768) | Diabetic (n = 430) | value |
| | Procedural | | | | 0.225 | | Transradial | 1181 (98.5%) | 736 (95.8%) | 418 (97.2%) | | | Transfemoral | 44 (3.6%) | 32 (4.1%) | 12 (2.7%) | | | Treated lesion | 1351 (100%) | 868 (64.2%) | 483 (35.7%) | 0.064 | | 1 lesion | 1051 (87.7%) | 674 (87.7%) | 377 (87.6%) | | | 2 lesions | 141 (11.8%) | 88 (11.4%) | 53 (12.3%) | | | 3 lesions | 6 (0.6%) | 6 (0.7%) | 0 (0%) | | | Lesion preparation | | | | | | Semicompliant balloon | 939 (78.4%) | 609 (79.2%) | 330 (76.7%) | 0.303 | | Semicompliant balloon diameter (mm) | 2 ± 0.2 | 2 ± 0.2 | 2 ± 0.2 | 0.647 | | Semicompliant balloon pressure (atm) | 8.2 ± 3.2 | 8.2 ± 1.2 | 8.3 ± 3.6 | 0.431 | | Lacrosse NSE® | 364 (30.4%) | 295 (38.4%) | 135 (39.7%) | 0.569 | | Lacrosse NSE® diameter (mm) | 2.3 ± 0.2 | 2.3 ± 0.2 | 2.3 ± 0.2 | 0.151 | | Cutting balloon | 130 (10.9%) | 81 (10.5%) | 49 (11.3%) | 0.651 | | Cutting balloon diameter (mm) | 2.5 ± 0.2 | 2.5 ± 0.2 | 2.5 ± 0.2 | 0.536 | | Scoreflex® | 51 (4.3%) | 35 (4.5%) | 16 (3.7%) | 0.492 | | Scoreflex® diameter (mm) | 2.2 ± 0.2 | 2.2 ± 0.2 | 2.2 ± 0.2 | 0.359 | | NC balloon | 207 (17.3%) | 137 (17.8%) | 70 (16.7%) | 0.493 | | NC balloon diameter (mm) | 2.5 ± 0.16 | 2.5 ± 0.17 | 2.5 ± 0.16 | 0.861 | | NC balloon pressure (atm) | 14.3 ± 2.4 | 14.1 ± 2.3 | 14.4 ± 3.5 | 0.347 | | Rotational atherectomy | 26 (2.2%) | 21 (2.7%) | 5 (1.1%) | 0.073 | | Burr diameter (mm) | 1.4 ± 0.1 | 1.4 ± 0.1 | — | — | | Dissection after predilation | | | 0.540 | | | Type A | 377 (31.4%) | 248 (32.2%) | 129 (30%) | 0.404 | | Type B | 159 (13.2%) | 99 (12.8%) | 60 (13.9%) | 0.603 | | Residual stenosis after predilation | 21.1 ± 11.2 | 20.4 ± 10.8 | 22.2 ± 11.8 | 0.020 | | Residual stenosis after DCB | 19.7 ± 11.5 | 19.3 ± 11.6 | 20.3 ± 11.4 | 0.145 | | DCB number | | | | 0.463 | | 1 DCB | 1119 (93.4%) | 716 (93.2%) | 403 (93.7%) | | | 2 DCB | 76 (6.3%) | 51 (6.6%) | 25 (5.8%) | | | 3 DCB | 3 (0.3%) | 1 (0.13%) | 2 (0.4%) | | | Stenosis (%) | 88.9 ± 9.4 | 88.9 ± 9.6 | 88.8 ± 9.1 | 0.890 | | RVD (mm) | 2.5 ± 0.7 | 2.5 ± 0.8 | 2.5 ± 0.2 | 0.366 | | DCB diameter (mm) | 2.4 ± 0.2 | 2.4 ± 0.2 | 2.4 ± 0.2 | 0.629 | | DCB length (mm) | 23.2 ± 9.3 | 23.3 ± 9.2 | 23 ± 9.4 | 0.660 | | DCB inflation pressure (atm) | 8.2 ± 3.2 | 8.1 ± 1.4 | 8.3 ± 5.1 | 0.416 | | DCB inflation time (s) | 60 ± 4.5 | 60.1 ± 4.9 | 59.9 ± 3.7 | 0.474 | | Dissection after DCB deployment | | | 0.773 | | | Type A | 338 (28.2%) | 218 (28.3%) | 120 (27.9%) | 0.860 | | Type B | 172 (14.4%) | 109 (14.1%) | 63 (14.6%) | 0.835 |
|
|
Statistically significant; DCB: drug-coated balloon; NC: noncompliant; RVD: reference vessel diameter. |
